|
|
|
|
| LEADER |
00000cz a2200000n 4500 |
| 001 |
1665985879 |
| 003 |
DE-627 |
| 005 |
20250206212419.0 |
| 008 |
190521n||aznnnabbn | aaa |c |
| 024 |
7 |
|
|a http://d-nb.info/gnd/1186718900
|2 uri
|
| 024 |
7 |
|
|a 0000-0002-1732-6029
|2 orcid
|
| 035 |
|
|
|a (DE-588)1186718900
|
| 035 |
|
|
|a (DE-627)1665985879
|
| 040 |
|
|
|a DE-627
|b ger
|c DE-627
|e rda
|
| 043 |
|
|
|c XA-IT
|
| 079 |
|
|
|a g
|b p
|c v
|q f
|v piz
|
| 100 |
1 |
|
|a Russo Spena, Tiziana
|
| 375 |
|
|
|a 2
|2 iso5218
|
| 400 |
1 |
|
|a Russo-Spena, Tiziana
|
| 400 |
1 |
|
|a Russo Spena, T.
|
| 400 |
1 |
|
|a Spena, Tiziana Russo
|
| 510 |
2 |
|
|0 (DE-627)77712971X
|0 (DE-576)400170620
|0 (DE-588)104685108X
|a Università degli Studi di Napoli Federico II
|4 affi
|w r
|i Affiliation
|e Affiliation
|
| 550 |
|
|
|a Dr.
|4 akad
|w r
|i Akademischer Grad
|
| 692 |
|
|
|a Di Paola, Nadia: What drives biopharmaceutical firms' exploratory openness?
|
| ORI |
|
|
|a SA-MARC-ixtheoc001.raw
|
| SUB |
|
|
|a IXT
|b 1
|
| TIT |
|
|
|a ixtheo
|
GND (1186718900)
ORCID (0000-0002-1732-6029)
Prometheus (1186718900)